Search
for
Sort by
Research 391–420 of 1000+
- Molecular crosstalk between lncRNA H19, miR-29a, and JAK2/STAT3 signaling in alopecia areata: a preliminary study
- Hedgehog signaling reprograms hair follicle niche fibroblasts to a hyper-activated state
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Perceived Stigma Among Adults With Alopecia Areata in the United States
- Cardiovascular risk in patients with scarring and nonscarring alopecias: Assessing the current state of evidence
- Small Molecule Wnt Pathway Modulators from Natural Sources: History, State of the Art and Perspectives
- The Roles of Non-coding RNA in the Development and Regeneration of Hair Follicles: Current Status and Further Perspectives
- The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience
- 695 Selectively targeting JAK1 or JAK3 pathway is sufficient to reverse alopecia areata
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Effectiveness of baricitinib in severe alopecia areata in real life: a retrospective study of 87 patients.
- Deuruxolitinib for Alopecia Areata.
- Role of janus kinase inhibitors in the treatment of alopecia areata
- Parsing patterns: Emerging roles of tissue self-organization in health and disease
- Immune therapies for alopecia areata: evidence and new perspectives
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Alopecia management from a comparative perspective: pharmacological and pharmaceutical insights in humans, dogs, and cats
- Molecular Mechanisms and Targeted Therapeutics in Androgenetic Alopecia: From Signaling Pathways to Regenerative Approaches
- Exploring novel management options for alopecia areata
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Alopecia Areata: Pathogenesis, current treatments, and future perspectives
- Review of efficacy of baricitinib in the treatment of alopecia areata
- 1332 Janus kinase inhibitor increases hair growth by increasing beta-catenin activity in outer root sheath cells
- Alopecia areata treatment with baricitinib: different relapse phenotypes
- Alopecia areata: medical treatments
- Alopecia – New building blocks
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy